We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+15.04%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$5.72B
AUM Growth
+$1.04B
Cap. Flow
+$416M
Cap. Flow %
7.27%
Top 10 Hldgs %
63.51%
Holding
50
New
7
Increased
15
Reduced
16
Closed
5

Top Buys

Rank Stock Value
1
CTVA icon
Corteva
CTVA
+$108M
2
ESI icon
Element Solutions
ESI
+$107M
3
ALIT icon
Alight
ALIT
+$91.6M
4
MRVL icon
Marvell Technology
MRVL
+$81.6M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$74.3M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$221M
2
THC icon
Tenet Healthcare
THC
+$127M
3
UBER icon
Uber
UBER
+$60M
4
AMZN icon
Amazon
AMZN
+$48.6M
5
CHTR icon
Charter Communications
CHTR
+$45.4M

Sector Composition

Rank Sector Weight
1 Healthcare 42.96%
2 Technology 19.46%
3 Materials 10.49%
4 Industrials 7.71%
5 Consumer Discretionary 5.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THC icon
1
Tenet Healthcare
THC
$20.1B
$665M 11.63%
6,327,203
-1,415,119
-18% -$127M
CI icon
2
Cigna
CI
$76.6B
$534M 9.35%
1,471,575
-670,951
-31% -$221M
CTVA icon
3
Corteva
CTVA
$59.7B
$391M 6.84%
6,786,273
+2,087,548
+44% +$108M
UHS icon
4
Universal Health Services
UHS
$9.43B
$375M 6.55%
2,054,548
+353,132
+21% +$58.3M
SPY icon
5
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$345M 6.04%
+660,000
New +$329M
GPN icon
6
Global Payments
GPN
$22.1B
$319M 5.58%
2,388,222
+440,094
+23% +$58.2M
ALIT icon
7
Alight
ALIT
$497M
$279M 4.88%
1,416,244
+506,143
+56% +$91.6M
DXC icon
8
DXC Technology
DXC
$1.63B
$271M 4.74%
12,783,034
-223,589
-2% -$4.88M
IWM icon
9
PUT
iShares Russell 2000 ETF
IWM
$80.9B
$243M 4.25%
1,155,300
-432,300
-27% -$86.2M
ESI icon
10
Element Solutions
ESI
$9.12B
$209M 3.65%
8,358,649
+4,596,029
+122% +$107M
CLVT icon
11
Clarivate
CLVT
$1.3B
$183M 3.2%
24,651,317
+270
+0% +$2.25K
MCK icon
12
McKesson
MCK
$98.5B
$155M 2.7%
287,961
-38,935
-12% -$19.8M
USFD icon
13
US Foods
USFD
$21.4B
$136M 2.38%
2,524,168
+770,439
+44% +$38M
CVS icon
14
CVS Health
CVS
$137B
$135M 2.37%
1,696,430
+950,286
+127% +$72.6M
FISV
15
Fiserv Inc
FISV
$27.2B
$128M 2.24%
802,692
-140,585
-15% -$20.5M
TEVA icon
16
Teva Pharmaceuticals
TEVA
$35.9B
$106M 1.85%
7,501,284
+5,896,651
+367% +$74.3M
MYGN icon
17
Myriad Genetics
MYGN
$530M
$105M 1.84%
4,943,595
-340,387
-6% -$7.32M
MRVL icon
18
Marvell Technology
MRVL
$174B
$97.1M 1.7%
1,370,604
+1,190,895
+663% +$81.6M
BKD icon
19
Brookdale Senior Living
BKD
$3.62B
$95.5M 1.67%
14,444,673
-2,500,000
-15% -$14.6M
ELV icon
20
Elevance Health
ELV
$81.9B
$90.3M 1.58%
174,229
+136,320
+360% +$67.8M
UBER icon
21
Uber
UBER
$134B
$86.9M 1.52%
1,128,814
-835,537
-43% -$60M
EXPE icon
22
Expedia Group
EXPE
$31.2B
$84.6M 1.48%
614,438
-86,823
-12% -$12.3M
KNX icon
23
Knight Transportation
KNX
$11.8B
$72.9M 1.27%
1,325,061
+469,484
+55% +$26.5M
VVV icon
24
Valvoline
VVV
$4.97B
$72.8M 1.27%
1,634,053
-686,120
-30% -$27.4M
AMZN icon
25
Amazon
AMZN
$2.5T
$72.7M 1.27%
402,942
-291,135
-42% -$48.6M
1
2

Similar funds

MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return

Glenview Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Glenview Capital Management held 50 positions worth $5.72B, up 22% from $4.68B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Glenview Capital Management deployed $416M of net new capital in Q1 2024, opening 7 new positions and adding to 15 existing holdings. Its largest new stake was Ginkgo Bioworks: 600,000 shares worth $27.8M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 45% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Cigna, an estimated $221M trimmed.

  • Glenview Capital Management's largest Q1 2024 buy was Ginkgo Bioworks: 600,000 shares worth $27.8M.
  • Glenview Capital Management added most to Corteva in Q1 2024, an estimated $108M increase.
  • Glenview Capital Management's biggest Q1 2024 reduction was Cigna, cutting an estimated $221M.
  • Glenview Capital Management fully exited Charter Communications in Q1 2024, selling an estimated $45.4M.
  • Glenview Capital Management's ten largest holdings make up 64% of its $5.72B portfolio in Q1 2024.
  • Glenview Capital Management opened 7 new positions and closed 5 in Q1 2024.
  • Glenview Capital Management's portfolio value rose 22% quarter-over-quarter to $5.72B.

Based on Glenview Capital Management's 13F filing for Q1 2024, filed 15 May 2024.